The greatest incidence of ROP blindness are among US patients with Hispanic ethnicity and those treated in Southern or Midwestern regions. Children with retinopathy of prematurity (ROP) are more ...

You will be redirected to our submission process. Given the success of Volume I of this Research Topic, and how rapid the subject area is evolving, we are pleased to announce the launch of ...

and retinopathy of prematurity (ROP) have become the important and increasing causes of retinal blindness. It is expected that there would be 57 million diabetics in India by 2025 and 137 million ...

Retinal vein occlusion is a common cause of vision loss in adults and the second most common retinal vascular disease. The low-dose form of Eylea is also approved to treat patients with retinopathy of ...

An increasing incidence of retinopathy of prematurity as seen in Latin America. An increasing urbanization. A lack of proper health policy. A lack of uniform accessible comprehensive and adequate ...

With a well-established efficacy and consistent safety profile from 16 pivotal trials, EYLEA is approved to treat vision-threatening conditions that impact patients from their earliest days, such as ...

The second, was Premacure AB, allowing Shire's HGT business to continue the ongoing development a protein replacement therapy for the treatment of retinopathy of prematurity (ROP). The third and ...

Background Implementing lipid control in patients with diabetes is regarded as a potential strategy for halting the advancement of diabetic retinopathy (DR). This study seeks to use Mendelian ...